Roche's arthritis drug lowers deaths in hospitalised Covid-19 patients
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
Drug vignettes: Tocilizumab - The Centre for Evidence-Based Medicine
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
Coronavirus : l'Actemra de Roche marque un point contre le Covid 19 | Les Echos
WHO Urges Covid-19 Treatment With Roche and Sanofi Anti-Inflammatory Drugs - WSJ
FDA Advisory No.2021-2407 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Tocilizumab Injection Actemra® 400 mg/ 20 mL” - Food and Drug Administration
Approval lapsed) RoActemra tocilizumab 400 mg/ 20mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Approval lapsed) RoActemra tocilizumab 200 mg/ 10mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential - Ghasemi - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
WHO prequalifies Roche's tocilizumab as its first monoclonal antibody treatment for COVID-19 - Homeland Preparedness News
Roche won't contest Hetero Drug's tocilizumab copy | Mint
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – Spicyip
Roche's Actemra fails to meet Phase III goals in Covid-19 patients
Roche warns of shortage of Covid-19 drug tocilizumab - The Hindu BusinessLine
Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
Tocilizumab Raises GI Risks in Rheumatoid Arthritis | MedPage Today
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
Is PMR the Next Indication for Tocilizumab? | MedPage Today
Buy RoActemra (tocilizumab) Online • Price & Costs | Everyone.org
